Last update 01 Nov 2024

DNARX LLC

Private Company|
2015|
United States
|
dnarx.net

Overview

Tags

Other Diseases
Respiratory Diseases
Hemic and Lymphatic Diseases
Biosimilar
Monoclonal antibody
Colony-stimulating factors

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases2
Endocrinology and Metabolic Disease1
Infectious Diseases1
Immune System Diseases1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Monoclonal antibody2
Biosimilar2
Colony-stimulating factors1
Prophylactic vaccine1
Biological products1
Top 5 TargetCount
IL-5(Interleukin-5)1
CD20(B-lymphocyte antigen CD20)1

Related

7
Drugs associated with DNARX LLC
G-CSF (DNARX)
Target-
Mechanism-
Active Org.
DNARX LLC
Originator Org.
DNARX LLC
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Growth hormone producing gene therapy (DNARx)
Target-
Mechanism
Gene transference
Active Org.
DNARX LLC
Originator Org.
DNARX LLC
Active Indication
Growth hormone deficiency
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
H1N1 Flu Vaccine (DNARX)
Target-
Mechanism
Immunostimulants
Active Org.
DNARX LLC
Originator Org.
DNARX LLC
Active Indication
influenza A subtype H1N1 infection
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with DNARX LLC
Login to view more data
0 Patents (Medical) associated with DNARX LLC
Login to view more data
1
Literatures (Medical) associated with DNARX LLC
01 Nov 2019Science AdvancesQ1 · CROSS-FIELD
Durable multitransgene expression in vivo using systemic, nonviral DNA delivery
Q1 · CROSS-FIELD
100 Deals associated with DNARX LLC
Login to view more data
100 Translational Medicine associated with DNARX LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
6
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
H1N1 Flu Vaccine (DNARX)
influenza A subtype H1N1 infection
More
Preclinical
Growth hormone producing gene therapy (DNARx)
Growth hormone deficiency
More
Preclinical
FVIII (DNARX)
Hemophilia
More
Preclinical
G-CSF (DNARX)
Neoplasms
More
Preclinical
Mepolizumab Biosimilar (DNARX)
 ( IL-5 )		Asthma
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free